These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35381344)

  • 1. Chronic graft-versus-host disease-related polymyositis and myocarditis: A case report and review of the literature.
    Yan M; Su F; Cheng F; Shi J; Zheng W; Luo Y; Wang J; Lu H; Zhou H; Huang H; Tan Y
    Transpl Immunol; 2022 Jun; 72():101598. PubMed ID: 35381344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic graft-versus-host disease presenting as acute polymyositis: A case series and systematic review.
    Shahzad M; Chaudhary SG; Basit A; Thellman C; Rodriguez L; Abhyankar SH; McGuirk JP; Mushtaq MU
    Transpl Immunol; 2022 Feb; 70():101520. PubMed ID: 34952168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case report and literature review of chronic graft-versus-host disease manifesting as polymyositis.
    Michelis FV; Bril V; Lipton JH
    Int J Hematol; 2015 Jul; 102(1):144-6. PubMed ID: 25732066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relapsing polymyositis in chronic graft versus host disease.
    Sharaf N; Prayson RA
    J Clin Neurosci; 2014 Nov; 21(11):1964-5. PubMed ID: 24980629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymyositis in a child with thalassemia after hematopoietic stem cell transplantation: A case report.
    Tan Y; Lin J; Hong X; Lu J; Lu Q
    Medicine (Baltimore); 2021 Oct; 100(41):e27388. PubMed ID: 34731108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymyositis and myocarditis after donor lymphocyte infusion.
    Ahn JS; Cho SH; Kim YK; Yang DH; Bae WK; Shim HJ; Lee JJ; Chung IJ; Juhng SW; Kim HJ
    Int J Hematol; 2009 Jul; 90(1):113-116. PubMed ID: 19472035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic graft-versus-host disease of the kidney in patients with allogenic hematopoietic stem cell transplant.
    Fraile P; Vazquez L; Caballero D; Garcia-Cosmes P; López L; San Miguel J; Tabernero JM
    Eur J Haematol; 2013 Aug; 91(2):129-34. PubMed ID: 23710658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic graft-versus-host disease manifesting as polymyositis: an uncommon presentation.
    Couriel DR; Beguelin GZ; Giralt S; De Lima M; Hosing C; Kharfan-Dabaja MA; Anagnostopoulos A; Champlin R
    Bone Marrow Transplant; 2002 Oct; 30(8):543-6. PubMed ID: 12379897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Ruxolitinib for Steroid-Refractory Chronic Graft-vs-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation.
    Wu H; Shi J; Luo Y; Tan Y; Zhang M; Lai X; Yu J; Liu L; Fu H; Huang H; Zhao Y
    JAMA Netw Open; 2021 Jan; 4(1):e2034750. PubMed ID: 33502484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic Graft-Versus-Host-Disease-Related Polymyositis: a 17-Months-Old Child with a Rare and Late Complication of Haematopoietic Stem Cell Transplantation.
    Chinello M; Balter R; De Bortoli M; Vitale V; Zaccaron A; Bonetti E; Tonin P; Vattemi G; Guglielmi V; Cesaro S
    Mediterr J Hematol Infect Dis; 2020; 12(1):e2020002. PubMed ID: 31934312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic graft-versus-host disease in children and adolescents with thalassemia after hematopoietic stem cell transplantation.
    Lertkovit O; Anurathapan U; Hongeng S; Thokanit NS; Pakakasama S
    Int J Hematol; 2021 Apr; 113(4):556-565. PubMed ID: 33385291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficiency and Toxicity of Ruxolitinib as a Salvage Treatment for Steroid-Refractory Chronic Graft-Versus-Host Disease.
    Wang D; Liu Y; Lai X; Chen J; Cheng Q; Ma X; Lin Z; Wu D; Xu Y
    Front Immunol; 2021; 12():673636. PubMed ID: 34276662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolated massive pleural effusion as a manifestation of chronic graft versus host disease successfully treated with corticosteroid.
    Masuda Y; Yamazaki S; Honda A; Masamoto Y; Kurokawa M
    Ann Hematol; 2024 Apr; 103(4):1403-1407. PubMed ID: 38285080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL6-receptor antibody tocilizumab as salvage therapy in severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a retrospective analysis.
    Kattner AS; Holler E; Holler B; Klobuch S; Weber D; Martinovic D; Edinger M; Herr W; Wolff D
    Ann Hematol; 2020 Apr; 99(4):847-853. PubMed ID: 32086584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The clinical characteristics of polyserositis as main presentation of chronic graft-versus-host rejection disease after allogeneic hematopoietic stem cell transplantation].
    Wang Q; Li Y; Qiu Z; Xu W; Sun Y; Wang L; Wang M; Liu W; Dong Y; Ou J; Wang W; Liang Z; Wang Q; Cen X; Ren H
    Zhonghua Nei Ke Za Zhi; 2014 May; 53(5):394-7. PubMed ID: 25146408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ruxolitinib for steroid-refractory graft versus host disease in pediatric HSCT: high response rate and manageable toxicity.
    Mozo Y; Bueno D; Sisinni L; Fernández-Arroyo A; Rosich B; Martínez AP; Benítez-Carabante MI; Alonso L; Uría ML; Heredia CD; Mestre-Duran C; Pascual CFB; Torres J; Losantos I; Escudero A; Ruz-Caracuel B
    Pediatr Hematol Oncol; 2021 May; 38(4):331-345. PubMed ID: 33661711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for chronic graft-versus-host disease after anti-thymocyte globulin-based haploidentical hematopoietic stem cell transplantation in acute myeloid leukemia.
    Lv M; Zhang X; Xu L; Wang Y; Yan C; Chen H; Chen Y; Han W; Wang F; Wang J; Liu K; Huang X; Mo X
    Front Med; 2019 Dec; 13(6):667-679. PubMed ID: 31512033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prophylaxis and treatment of chronic graft versus host disease].
    Huang K; Li Y; Huang SL; Fang JP; Zhou DH; Chen C
    Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):174-7. PubMed ID: 15833186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic graft versus host disease of oral mucosa: review of available therapies.
    Imanguli MM; Pavletic SZ; Guadagnini JP; Brahim JS; Atkinson JC
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Feb; 101(2):175-83. PubMed ID: 16448918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ruxolitinib for the treatment of steroid refractory pediatric chronic graft-versus-host disease.
    Belina ME; Driscoll TA; Blanchard SK; Cardones AR
    Pediatr Dermatol; 2022 May; 39(3):432-433. PubMed ID: 35234308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.